UNILAB, Inc.
UNILAB, Inc., a leading pharmaceutical company based in the Philippines, has been a cornerstone of the healthcare industry since its establishment in 1945. Headquartered in Quezon City, UNILAB operates extensively across the Philippines and has a growing presence in various international markets. Specialising in the development, manufacturing, and distribution of high-quality pharmaceutical products, UNILAB offers a diverse portfolio that includes prescription medications, over-the-counter drugs, and consumer health products. What sets UNILAB apart is its commitment to innovation and quality, ensuring that its offerings meet the highest standards of safety and efficacy. With a strong market position, UNILAB has achieved numerous accolades, solidifying its reputation as a trusted name in healthcare. The company continues to lead the way in addressing the evolving needs of patients and healthcare professionals alike.
DitchCarbon Score
How does UNILAB, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
UNILAB, Inc.'s score of 7 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
UNILAB, Inc.'s reported carbon emissions
UNILAB, Inc., headquartered in the Philippines, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. In the absence of specific emissions data, it is important to note that UNILAB has not outlined any formal reduction targets or climate pledges. This lack of publicly available information suggests that the company may still be in the early stages of developing its climate commitments or reporting frameworks. As the pharmaceutical industry increasingly prioritises sustainability, UNILAB's future initiatives may align with broader industry trends towards reducing carbon footprints and enhancing environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
UNILAB, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
